Treatment and low-density lipoprotein cholesterol levels in patients with hypercholesterolaemia or mixed dyslipidaemia at high or very high cardiovascular risk: a population-based cross-sectional study in the Netherlands-Reference-Cited by-同舟云学术

Treatment and low-density lipoprotein cholesterol levels in patients with hypercholesterolaemia or mixed dyslipidaemia at high or very high cardiovascular risk: a population-based cross-sectional study in the Netherlands

Published:2022-10-14 Issue:1 Volume:39 Page:1-11
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Heintjes Edith M.¹^ORCID,Anastassopoulou Anastassia²^ORCID,Kuiper Josephina¹^ORCID,Bilitou Aikaterini²^ORCID,Beest Fernie J. A. Penning-van¹^ORCID,Herings Ron M. C.¹³^ORCID,Postma Maarten J.⁴⁵^ORCID,Jukema J. Wouter⁶⁷^ORCID

Affiliation:

1. PHARMO Institute for Drug Outcomes Research, Utrecht, the Netherlands

2. Market Access Europe, Daiichi Sankyo Europe GmbH, Munich, Germany

3. Pharmacoepidemiology & Health Care Optimization, Department of Epidemiology & Data Science, Amsterdam Public Health Research Institute, Amsterdam UMC (Location VUmc), Amsterdam, the Netherlands

4. Department of Health Sciences, University Medical Center Groningen, Groningen, the Netherlands

5. Department of Economics, Econometrics & Finance, Faculty of Economics & Business, University of Groningen, Groningen, the Netherlands

6. Department of Cardiology, Leiden University Medical Center, Leiden, the Netherlands

7. Netherlands Heart Institute, Utrecht, the Netherlands

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/03007995.2022.2129228

Reference42 articles.

1. Utilization of lipid-modifying therapy and low-density lipoprotein cholesterol goal attainment in patients at high and very-high cardiovascular risk: Real-world evidence from Germany

2. Cardiovascular disease in Europe

3. European Society of Cardiology: Cardiovascular Disease Statistics 2019

4. Cardiovascular risk factors are associated with subclinical atherosclerosis in high functioning older adults

5. Lipid Target in Very High-Risk Cardiovascular Patients: Lesson from PCSK9 Monoclonal Antibodies

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. BTK inhibitors: moving the needle on the treatment of chronic lymphocytic leukemia;Expert Review of Hematology;2024-08-21

2. Real-world data on treatment patterns in at least high cardiovascular risk patients on dual and triple lipid lowering therapy in a Hellenic nationwide e-prescription database;International Journal of Cardiology Cardiovascular Risk and Prevention;2024-06